College of Medicine
UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center
Home — College of Medicine — Department of Dermatology — Research — Clinical Research

Clinical Research

Registries

For information about studies, email the Research Office or call 402-559-3825.

Dermatology Patient Data Registry
The purpose is to collect retrospective and prospective demographic, clinical (including photographs), survey data, pathology, management and outcome data relevant to numerous skin cancers, tumors and dermatologic diseases of interest. We will assess where there are gaps in access to care and teledermatology and current knowledge surrounding presentation, prognosis, management and outcomes. We will have separate sections for the various types of skin cancer, tumors and dermatologic diagnoses.
Integrated Cancer Repository for Cancer Research: The iCaRe2

The Integrated Cancer Respository for Cancer Research is a multi-institutional resource created and maintained by the Fred & Pamela Buffett Cancer Center to collect and manage standardized, multidimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls.  UNMC Dermatology is involved in iCaRe2 for melanoma, squamous cell carcinoma, basal cell carcinoma, merkel cell carcinoma and other rare cutaneous tumors.

Studies Currently Enrolling

Quality of Life and Venolymphatic Disease: A prospective study 

To assess physical implications of chronic vascular disease on quality of life with the goal of validating the experiences of the patient and the efficacy of endovenous laser ablation and endovenous chemical ablation for this highly morbid disease. 

To be eligible for this study, individuals must: 

  • Have chronic vascular disease  
  • Be 19 years or older  
  •  Be able to provide informed consent 

Dermatology Tissue Bank 

The bank collects tissue and/or blood from patients with dermatologic conditions for the purpose of future genetic, cellular, molecular and clinical database studies 

To be eligible for this study, individuals must: 

  • Have a dermatologic condition and be having a biopsy and/or blood drawn   
  • Be 19 years or older  
  • Be able to provide informed consent 

Hyaluronidase via Laser-Assisted Drug Delivery for the Treatment of Scleroderma-induced Microstomia

To be eligible for this study, individuals must: 

  • Have diagnosed scleroderma-induced microstomia. Not previously treated with hyaluronidase, LADD, or ablative CO2 laser treatment.
  • Be 19 years or older  
  •  Be able to provide informed consent 


Coagulopathy of Immunodermatologic Diseases

Diagnosis of immune-mediated skin disease including but not limited to bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, cutaneous lupus erythematosus, dermatomyositis.

To be eligible for this study, individuals must: 

  •  Have diagnosis of immune-mediated skin disease including but not limited to bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, cutaneous lupus erythematosus, dermatomyositis
  • Be 19 years or older  
  •  Be able to provide informed consent 


Integration of patient satisfaction, functional status, and quality of life in determining appropriateness of skin cancer treatment in advanced age and high-risk patients

To be eligible for this study, individuals must: 

  • Have Non-Melanoma Skin Cancer
  • Be 19 years or older  
  •  Be able to provide informed consent